Human Laboratory Study of Smokeless Tobacco Products
Treatment will be a 3-period crossover study using Commit Nicotine Lozenge, Stonewall
Disposable Tobacco Pieces and Camel Snus Frost Pouches. Each period will last 14 days with
11 days of product use and 1.5 days abstinence of all nicotine-containing products for a
total of 10 weeks. Participants will begin the study by completing a baseline assessment on
their own product, Skoal Wintergreen.
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
Comparing withdrawal symptoms between the different products - 4 mg nicotine lozenge (LOZ), Camel Snus Frost (SNUS), Stonewall Spearmint Tablet (STAB), and Skoal Wintergreen (SKOL).
Marc Mooney, Ph.D.
Dept. Psychiatry, University of Minnesota
United States: Institutional Review Board
|Tobacco Research Center||Minneapolis, Minnesota 55455|